These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17822717)

  • 21. A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats.
    Sejima E; Yamauchi A; Nishioku T; Koga M; Nakagama K; Dohgu S; Futagami K; Kataoka Y
    Cell Mol Neurobiol; 2011 Oct; 31(7):985-9. PubMed ID: 21681559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.
    Kalinichev M; Rourke C; Daniels AJ; Grizzle MK; Britt CS; Ignar DM; Jones DN
    Psychopharmacology (Berl); 2005 Oct; 182(2):220-31. PubMed ID: 16001110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.
    Kluge M; Schuld A; Himmerich H; Dalal M; Schacht A; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T
    J Clin Psychopharmacol; 2007 Dec; 27(6):662-6. PubMed ID: 18004133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model for antipsychotic-induced obesity in the male rat.
    Minet-Ringuet J; Even PC; Lacroix M; Tomé D; de Beaurepaire R
    Psychopharmacology (Berl); 2006 Sep; 187(4):447-54. PubMed ID: 16783538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Han M; Deng C
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):827-35. PubMed ID: 18257959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sex-dependent impact of chronic clozapine and haloperidol treatment on characteristics of the metabolic syndrome in a rat model.
    von Wilmsdorff M; Bouvier ML; Henning U; Schmitt A; Schneider-Axmann T; Gaebel W
    Pharmacopsychiatry; 2013 Jan; 46(1):1-9. PubMed ID: 22915487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo 5-HT(6) receptor occupancy by antipsychotic drugs in the rat brain.
    Hirano K; Searle KL; Nasir S; Aw CC; Browne ER; Rutter AR
    Neurosci Lett; 2011 Oct; 503(3):240-3. PubMed ID: 21896308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects.
    Skrede S; Martins L; Berge RK; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):91-104. PubMed ID: 23919889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity.
    He M; Zhang Q; Deng C; Jin T; Song X; Wang H; Huang XF
    Psychoneuroendocrinology; 2017 Nov; 85():190-199. PubMed ID: 28886461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of olanzapine-induced weight gain by the retinoid analog AM-80.
    Richards M; Chiba S; Ninomiya M; Wakabayasi C; Kunugi H
    Pharmacopsychiatry; 2013 Nov; 46(7):267-73. PubMed ID: 24105080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats.
    Ortega-Alvaro A; Gibert-Rahola J; Micó JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):104-11. PubMed ID: 16226364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats.
    Belanoff JK; Blasey CM; Clark RD; Roe RL
    Eur J Pharmacol; 2011 Mar; 655(1-3):117-20. PubMed ID: 21269600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
    Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
    J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol drinking of alcohol-preferring AA rats is differentially affected by clozapine and olanzapine.
    Ingman K; Korpi ER
    Eur J Pharmacol; 2006 Mar; 534(1-3):133-40. PubMed ID: 16480711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human.
    Pouzet B; Mow T; Kreilgaard M; Velschow S
    Pharmacol Biochem Behav; 2003 Apr; 75(1):133-40. PubMed ID: 12759121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An animal model of antipsychotic-induced weight gain.
    Arjona AA; Zhang SX; Adamson B; Wurtman RJ
    Behav Brain Res; 2004 Jun; 152(1):121-7. PubMed ID: 15135975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A parametric analysis of olanzapine-induced weight gain in female rats.
    Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model.
    Horska K; Kucera J; Drazanova E; Kuzminova G; Amchova P; Hrickova M; Ruda-Kucerova J; Skrede S
    Biomed Pharmacother; 2024 Jul; 176():116763. PubMed ID: 38805968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats.
    Babic I; Gorak A; Engel M; Sellers D; Else P; Osborne AL; Pai N; Huang XF; Nealon J; Weston-Green K
    J Psychopharmacol; 2018 May; 32(5):578-590. PubMed ID: 29493378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.
    Beebe KL; Block T; Debattista C; Blasey C; Belanoff JK
    Behav Brain Res; 2006 Aug; 171(2):225-9. PubMed ID: 16782211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.